- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/12 - Viral antigens
Patent holdings for IPC class A61K 39/12
Total number of patents in this class: 9850
10-year publication summary
|
590
|
675
|
709
|
841
|
765
|
859
|
849
|
751
|
656
|
324
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1637 |
240 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2847 |
195 |
| The Trustees of the University of Pennsylvania | 4317 |
140 |
| Janssen Vaccines & Prevention B.V. | 295 |
134 |
| Intervet Inc. | 905 |
124 |
| Intervet International B.V. | 1282 |
117 |
| Zoetis Services LLC | 1539 |
104 |
| Takeda Vaccines, Inc. | 217 |
103 |
| Modernatx, Inc. | 1259 |
94 |
| The Regents of the University of California | 19887 |
82 |
| Inovio Pharmaceuticals, Inc. | 319 |
81 |
| Boehringer Ingelheim Vetmedica GmbH | 1267 |
80 |
| Boehringer Ingelheim Animal Health USA Inc. | 417 |
78 |
| Immatics Biotechnologies GmbH | 1156 |
76 |
| Duke University | 3065 |
70 |
| Institut Pasteur | 785 |
70 |
| The Wistar Institute of Anatomy and Biology | 449 |
65 |
| Massachusetts Institute of Technology | 10041 |
60 |
| Bavarian Nordic A/S | 257 |
60 |
| Curevac SE | 264 |
58 |
| Other owners | 7819 |